2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of theGastric Cancer Diagnostic Procedure Market?
The spike in gastrointestinal ailments is propelling the gastric cancer diagnostic procedure market’s expansion. Gastrointestinal disorders, which impact various parts of the digestive system and supportive organs like the liver and pancreas, are driving the need for gastric cancer diagnostic process utilized in treating stomach cancer, such as endoscopic procedures and biopsies. Thus, the increasing occurrence of gastrointestinal diseases is augmenting the growth of the gastric cancer diagnostic procedure market. For example, a report issued by GI Associates & Endoscopy Center, a US-based gastroenterology service provider, in August 2022 stated that out of 73,076 people studied across 33 countries, a staggering 40% suffered from a functional gastrointestinal disease. Consequently, the escalation in gastrointestinal diseases directly impacts the growth of the gastric cancer diagnostic procedure market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp
#What Growth Opportunities Will Drive the Gastric Cancer Diagnostic Procedure Market’s CAGR Through 2034?
The market for diagnostic procedures for gastric cancer has seen a robust growth in the past few years. Its size is projected to rise from $1.44 billion in 2024 to $1.54 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The previous growth can be credited to advancements in biopsy methodologies, escalated funding for research, development of biomarker discovery, enhanced analysis in pathology, and changes in screening regulations.
In the coming years, the market size for gastric cancer diagnostic procedures is predicted to experience robust growth. The market is projected to reach $2.07 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%. This growth throughout the forecast period can be linked to factors such as the rise in point-of-care testing, the emergence of new biomarkers, a shift towards personalized medicine, the adoption of next-generation sequencing, and improvements in endoscopic imaging modalities. Key trends for the forecast period encompass the integration of nanotechnology, the utilisation of big data analytics, the involvement of microbiota analysis, the rising patient-centric strategies, and the role of telehealth in diagnostics.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12038
How Are Consumer Market Innovations Shaping the Current and Future Landscape of theGastric Cancer Diagnostic Procedure Market?
The gastric cancer diagnostic market is seeing a trend in technological developments. Big players in the market are integrating novel technologies to maintain their market standing. Case in point, Ibex Medical Analytics, which specializes in AI-based diagnostic solutions in Israel, introduced Galen Gastric in June 2022. This is the first-ever AI-driven technology meant for detecting gastric cancer. Galen Gastric is a comprehensive diagnostic device designed to assist pathologists in detecting stomach cancer, H. pylori, and other important clinical observations. It also promotes speedy turnaround times and enhances diagnostic procedures.
Who Are the Key Market Players Influencing the Growth of the Corn and Gastric Cancer Diagnostic Procedure Industry?
Major companies operating in the gastric cancer diagnostic procedure market include Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc, Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Gastric Cancer Diagnostic Procedure Market and Drive Its Revenue Growth?
The gastric cancer diagnostic procedure market covered in this report is segmented –
1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types
2) By Symptom Type: Symptomatic, Asymptomatic
3) By Offering Type: Instruments, Reagents And Consumables, Services
4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid
5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer
Subsegments:
1) By Endoscopic Procedure: Upper Endoscopy (EGD), Endoscopic Ultrasound (EUS)
2) By Biopsy: Endoscopic Biopsy, Fine Needle Aspiration (FNA) Biopsy
3) By Tissue Tests: Histopathology, Immunohistochemistry
4) By Lab Tests: Blood Tests, Tumor Markers
5) By In-Vitro Diagnostic Tests: Genetic Testing, Molecular Profiling
6) By Imaging Tests: Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scan
7) By Molecular Diagnostics: PCR Testing, Next-Generation Sequencing (NGS)
8) By Multiplexing Molecular Diagnostics: Multiplex PCR, Microarray Analysis
9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
10) By Other Procedure Types: Breath Tests, Liquid Biopsies
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12038&type=smp
Which Regions Are Emerging as Leaders in the Gastric Cancer Diagnostic Procedure Market?
North America was the largest region in the gastric cancer diagnostics procedure market in 2024. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Gobal Gastric Cancer Diagnostic Procedure Maret 2025, By The Business Research Company:
Mobility Aids And Transportation Equipment Global Market Report 2024
Passenger Air Transport Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/passenger-air-transport-global-market-report
Chartered Air Transport Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/chartered-air-transport-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
